Enlivex Granted EU Orphan Drug Designation for Lead Product ApoCell for Graft-Versus-Host Disease
January 26, 2015 09:17 ET
|
Hadasit Bio-Holdings Ltd.
JERUSALEM, Jan. 26, 2015 (GLOBE NEWSWIRE) -- Enlivex Therapeutics (Enlivex), a Hadasit Bio-Holdings ("HBL") (TASE:HDST) (OTCQB:HADSY) portfolio company, today announced that the European Medicines...